Congressional Republicans demand reinstatement of safety standards for ABORTION pills – NaturalNews.com

• Over 170 congressional Republicans demand the Trump administration reinstate strict FDA safety protocols for abortion pills, reversing Biden-era policies that allowed mail-order distribution without medical oversight.
• Data shows one in 10 women suffer life-threatening complications (hemorrhage, sepsis, etc.) – 22 times higher than the FDA’s claimed 0.5% risk. ER visits for telemedicine abortions are three times higher than in-person procedures.
• The FDA ignored its own data showing hospitalization rates 330% above the drug’s label. Critics accuse the agency of relying on industry-funded studies while removing safeguards like in-person screenings for ectopic pregnancy and coercion prevention.
• The Biden administration exploited COVID to permanently scrap safety rules – enabling coercion, abuse and illegal distribution even in pro-life states. The Supreme Court refused to challenge Biden’s reinterpretation of the 1873 Comstock Act, allowing abortion pills to flood the U.S. by mail.
• Planned Parenthood’s 2023 report shows chemical abortions now make up 64% of all U.S. abortions, with clinics shifting to mail-order models for higher profits – despite rising complications and lack of medical oversight.

In a dramatic escalation of the abortion policy battle, more than 170 congressional Republicans have demanded the Trump administration reinstate critical safety measures for abortion pills, reversing a Biden-era policy that allowed mail-order distribution without medical oversight.

The demand came in the form of a Nov. 20 letter spearheaded by Reps. Chris Smith (R-NJ) and Diana Harshbarger (R-TN), which was addressed to Health Secretary Robert F. Kennedy Jr. and Food and Drug Administration (FDA) Commissioner Dr. Marty Makary. It cited alarming new data showing that mifepristone – the drug responsible for over half of all U.S. abortions – poses severe, underreported risks to women, including life-threatening complications in nearly 11% of cases.

The letter also highlighted an explosive April 2024 study by the Ethics and Public Policy Center (EPPC) analyzing 865,727 mifepristone cases. It found that one in ten women suffered hemorrhage, sepsis or other emergencies – a rate 22 times higher than FDA claims.

Moreover, it exposed how the FDA under former President Joe Biden ignored its own data showing hospitalization rates 330% above the drug’s label, with 7% of women requiring emergency care. Disturbingly, telemedicine abortions – where pills are prescribed via online consultations – resulted in ER visits at nearly three times the rate of in-person visits.

“The Biden administration used COVID as a smokescreen to advance its radical abortion agenda,” the lawmakers wrote, noting that 70% of voters now support restoring safety standards. The policy’s human cost is stark: Women like Louisiana’s Rosalie Markezich, whose boyfriend secretly ordered mifepristone by mail and coerced her into taking it, exemplify how the system enables abuse.

FDA’s abandoned safeguards literally leave women bleeding

The push comes as the Supreme Court declined to challenge the Biden administration’s reinterpretation of the 1873 Comstock Act, which had previously barred mailing abortion-inducing drugs – a move critics say was engineered to bypass state abortion bans and flood the country with chemical abortions.

The controversy traces back to the Biden administration’s 2023 decision to permanently scrap the FDA’s Risk Evaluation and Mitigation Strategy for mifepristone, eliminating requirements that the drug be dispensed in person by a physician. Previously, these safeguards ensured women received screenings for ectopic pregnancy, gestational age verification and protection from coercion. But now, these are all absent in a system where pills are shipped directly to homes – even in states where abortion is illegal.

BrightU.AI‘s Enoch engine warns that mail-order abortions pose serious health risks – including hemorrhage, infection and sepsis – due to the lack of medical supervision and potential misuse beyond FDA-approved limits. Pro-life medical experts warn that this underregulated practice endangers women by bypassing essential safeguards and proper oversight.

The financial motives are equally glaring. Planned Parenthood’s latest report reveals 392,715 abortions in 2023 – a record high, with chemical abortions surging to 64% of all procedures. Operation Rescue documented a net loss of 36 surgical abortion clinics in 2022, yet new facilities specializing in mifepristone proliferated, underscoring the industry’s pivot to profit-driven mail-order models.

Meanwhile, Trump’s Department of Health and Human Services has sent mixed signals. While Kennedy pledged a “complete review” of mifepristone’s risks, no timeline has been set and the administration has yet to challenge the Comstock reversal.  With chemical abortions now two-thirds of all U.S. terminations, the GOP lawmakers warned that Biden’s “no-contact” scheme has turned the postal service into an abortion pipeline – one that sacrifices women’s health for ideological convenience.

Watch Tucker Carlson and Rebeccah Heinrichs discussing Bidenomics and abortion in this clip.

This video is from the Son of the Republic channel on Brighteon.com.

Sources include:

LifeSiteNews.com

ChrisSmith.House.gov ^[PDF]

BrightU.ai

Brighteon.com